Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine G. Kohn, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Costa OS, Kohn CG, Kuderer NM, Lyman GH, Bunz TJ, Coleman CI. Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism. Blood Adv. 2020 09 08; 4(17):4045-4051. PMID: 32853381.
    Citations: 1     Fields:    Translation:Humans
  2. Dolinar R, Kohn CG, Lavernia F, Nguyen E. The non-medical switching of prescription medications. Postgrad Med. 2019 Jun; 131(5):335-341. PMID: 31081414.
    Citations: 8     Fields:    Translation:Humans
  3. Kohn CG, Alberts MJ, Peacock WF, Bunz TJ, Coleman CI. Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample. Atherosclerosis. 2019 07; 286:142-146. PMID: 31170647.
    Citations: 8     Fields:    Translation:Humans
  4. Kohn CG, Singh P, Korytowsky B, Caranfa JT, Miller JD, Sill BE, Marshall AC, Parikh ND. Humanistic and economic burden of hepatocellular carcinoma: systematic literature review. Am J Manag Care. 2019 02; 25(2 Spec No.):SP61-SP73. PMID: 30776212.
    Citations: 5     Fields:    Translation:Humans
  5. Kohn CG, Bunz TJ, Beyer-Westendorf J, Coleman CI. Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism. Eur J Haematol. 2019 Feb; 102(2):143-149. PMID: 30328143.
    Citations:    Fields:    Translation:HumansPHPublic Health
  6. Nguyen E, Coleman CI, Kohn CG, Weeda ER. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018 Dec 15; 273:34-38. PMID: 30266352.
    Citations: 2     Fields:    Translation:Humans
  7. Weeda ER, Caranfa JT, Lyman GH, Kuderer NM, Nguyen E, Coleman CI, Kohn CG. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2019 Mar; 27(3):921-925. PMID: 30090992.
    Citations: 2     Fields:    Translation:Humans
  8. Nguyen E, Weeda ER, Kohn CG, D'Souza BA, Russo AM, Noreika S, Coleman CI. Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis. J Innov Card Rhythm Manag. 2018 May; 9(5):3151-3162. PMID: 32477809; PMCID: PMC7252786.
    Citations: 6     
  9. Kohn CG, Lyman GH, Beyer-Westendorf J, Spyropoulos AC, Bunz TJ, Baker WL, Eriksson D, Meinecke AK, Coleman CI. Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis. J Natl Compr Canc Netw. 2018 05; 16(5):491-497. PMID: 29752323.
    Citations: 7     Fields:    Translation:Humans
  10. Caranfa JT, Nguyen E, Ali R, Francis I, Zichichi A, Bosco E, Coleman CI, Baker WL, Kohn CG. Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices. PLoS One. 2018; 13(3):e0191657. PMID: 29513676.
    Citations: 1     Fields:    Translation:Humans
  11. Weeda ER, Caranfa JT, Zeichner SB, Coleman CI, Nguyen E, Kohn CG. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer. J Natl Compr Canc Netw. 2017 12; 15(12):1476-1482. PMID: 29223985.
    Citations: 3     Fields:    Translation:Humans
  12. Kohn CG, Fermann GJ, Peacock WF, Wells PS, Baugh CW, Ashton V, Crivera C, Schein JR, Wildgoose P, Coleman CI. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703. PMID: 28665208.
    Citations: 4     Fields:    Translation:Humans
  13. Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR. Reply to Á. Benedict et al. J Clin Oncol. 2017 09 10; 35(26):3086-3087. PMID: 28715248.
    Citations:    Fields:    Translation:Humans
  14. Zeichner SB, Goldstein DA, Kohn C, Flowers CR. Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma. J Gastrointest Oncol. 2017 Jun; 8(3):513-523. PMID: 28736638; PMCID: PMC5506269.
    Citations: 7     
  15. Nguyen E, Peacock WF, Fermann GJ, Ashton V, Crivera C, Wildgoose P, Schein JR, Bunz TJ, Coleman CI, Kohn CG. External validation of the multivariable 'In-hospital Mortality for PulmonAry embolism using Claims daTa' prediction rule in the Premier Hospital Database. Eur Heart J Qual Care Clin Outcomes. 2017 04 01; 3(2):157-159. PMID: 28927177.
    Citations: 1     Fields:    Translation:Humans
  16. Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR. Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma. J Clin Oncol. 2017 Apr 10; 35(11):1194-1202. PMID: 28221865; PMCID: PMC5791832.
    Citations: 45     Fields:    Translation:Humans
  17. Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. 2017 Aug; 12(5):613-619. PMID: 28185131.
    Citations: 3     Fields:    Translation:Humans
  18. Zeichner SB, Kohn CG, Goldstein DA. Economics of ramucirumab for metastatic colorectal cancer. Expert Rev Pharmacoecon Outcomes Res. 2016 Dec; 16(6):733-745. PMID: 27828732.
    Citations: 1     Fields:    Translation:Humans
  19. Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):187-196. PMID: 27654970; PMCID: PMC5329168.
    Citations: 11     Fields:    Translation:Humans
  20. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115. PMID: 27548074.
    Citations: 7     Fields:    Translation:Humans
  21. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2017 Oct; 23(7):769-774. PMID: 27225840.
    Citations: 7     Fields:    Translation:Humans
  22. Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI. External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J. 2016; 14:7. PMID: 26977136; PMCID: PMC4790043.
    Citations: 9     
  23. Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ. Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients. Curr Med Res Opin. 2016 06; 32(6):991-6. PMID: 26824145.
    Citations: 5     Fields:    Translation:Humans
  24. Rozjabek HM, Coleman CI, Weeda ER, Peacock WF, Fermann GJ, Crivera C, Schein JR, Kohn CG. Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination. Thromb Res. 2016 May; 141:8-10. PMID: 26946105.
    Citations: 2     Fields:    Translation:Humans
  25. Coleman CI, Freemantle N, Kohn CG. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective. BMJ Open. 2015 Nov 06; 5(11):e008861. PMID: 26546142; PMCID: PMC4636621.
    Citations: 3     Fields:    Translation:Humans
  26. Coleman CI, Kohn CG, Crivera C, Schein JR, Peacock WF. Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open. 2015 Oct 28; 5(10):e009251. PMID: 26510731.
    Citations: 11     Fields:    Translation:Humans
  27. Coleman CI, Kohn CG, Bunz TJ. Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule. Curr Med Res Opin. 2015 Aug; 31(8):1461-8. PMID: 26074196.
    Citations: 6     Fields:    Translation:Humans
  28. Mearns ES, Sobieraj DM, White CM, Saulsberry WJ, Kohn CG, Doleh Y, Zaccaro E, Coleman CI. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis. PLoS One. 2015; 10(4):e0125879. PMID: 25919293.
    Citations: 50     Fields:    Translation:Humans
  29. Kohn CG, Mearns ES, Parker MW, Hernandez AV, Coleman CI. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest. 2015 Apr; 147(4):1043-1062. PMID: 25317677.
    Citations: 31     Fields:    Translation:Humans
  30. Mearns ES, White CM, Kohn CG, Hawthorne J, Song JS, Meng J, Schein JR, Raut MK, Coleman CI. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014; 12:14. PMID: 25024644.
    Citations: 36     
  31. Mearns ES, Kohn CG, Song JS, Hawthorne J, Meng J, White CM, Raut MK, Schein JR, Coleman CI. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients. Thromb Res. 2014 Aug; 134(2):310-9. PMID: 24935672.
    Citations: 11     Fields:    Translation:Humans
  32. Kohn CG, Coleman CI, Michael White C, Sidovar MF, Sobieraj DM. Mobility, walking and physical activity in persons with multiple sclerosis. Curr Med Res Opin. 2014 Sep; 30(9):1857-62. PMID: 24803286.
    Citations: 3     Fields:    Translation:Humans
  33. Kohn CG, Sidovar MF, Kaur K, Zhu Y, Coleman CI. Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis. Health Qual Life Outcomes. 2014 May 05; 12:66. PMID: 24886430.
    Citations: 13     Fields:    Translation:Humans
  34. Kohn CG, Parker MW, Limone BL, Coleman CI. Impact of angina frequency on health utility values of patients with chronic stable angina. Health Qual Life Outcomes. 2014 Mar 14; 12:39. PMID: 24628859.
    Citations: 2     Fields:    Translation:Humans
  35. Kohn CG, Parker MW, Limone BL, Coleman CI. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris. Am J Cardiol. 2014 Apr 15; 113(8):1306-11. PMID: 24560062.
    Citations: 6     Fields:    Translation:Humans
  36. Kohn C, Saleheen H, Borrup K, Rogers S, Lapidus G. Correlates of drug use and driving among undergraduate college students. Traffic Inj Prev. 2014; 15(2):119-24. PMID: 24345012.
    Citations: 6     Fields:    Translation:Humans
  37. Kohn CG, Baker WL, Sidovar MF, Coleman CI. Walking speed and health-related quality of life in multiple sclerosis. Patient. 2014; 7(1):55-61. PMID: 24078332.
    Citations: 12     Fields:    Translation:Humans
  38. Kohn CG, Kluger J, Azeem M, Coleman CI. Short-term consequences of angiographically-confirmed coronary stent thrombosis. PLoS One. 2013; 8(10):e77330. PMID: 24143219.
    Citations: 4     Fields:    Translation:Humans
  39. Coleman CI, Sidovar MF, Roberts MS, Kohn C. Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis. PLoS One. 2013; 8(1):e54756. PMID: 23355896.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kohn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (147)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.